Report cover image

Military and Defense Semiconductor Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Publisher Global Market Insights
Published Nov 05, 2024
Length 150 Pages
SKU # GMI19463492

Description

Military and Defense Semiconductor Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032


The global military & defense semiconductor market was valued at USD 25 Billion in 2023 and is predicted to record an 8% CAGR from 2024 to 2032, primarily propelled by the relentless pace of technological advancements and the escalating defense expenditures worldwide. This market's growth is intricately linked to the modernization efforts of armed forces globally, as nations increasingly recognize the critical role played by advanced semiconductor solutions in shaping the capabilities of contemporary military applications.

According to the latest news, in December 2023, the US Army partnered with USC Institute for Creative Technologies to develop a new app for soldiers to teach them how to use AI tools. Game-If-AI, the app, will help personnel deployed in non-technical and technical areas. As defense agencies invest heavily in the integration of AI, ML, and edge computing into their systems, the demand for cutting-edge semiconductor solutions continues to soar, setting the stage for unprecedented growth in the Military & Defense Semiconductor Market.

The military & defense semiconductor market is classified based on mounting technology, application, and region.

The weapons application segment is anticipated to generate massive revenues in the market by 2032 due to the integration of semiconductors in precision-guided munitions. Electronic warfare systems, and smart weapons have become indispensable for modern military capabilities. The relentless pursuit of accuracy, range, and efficiency in weaponry is driving investments in semiconductor technologies that enhance the performance and reliability of defense systems.

The through hole technology mounting segment will grow significantly through 2032 owing to its role in ensuring robust connectivity and durability in harsh operational environments. Through hole technology, with its ability to provide mechanical strength and stability to components, is crucial for applications where reliability is paramount. This segment is experiencing a surge in demand as military and defense systems require semiconductors that can withstand extreme conditions while maintaining optimal performance.

Europe Military & Defense Semiconductor Market is expected to expand significantly by 2032, exhibiting substantial growth and innovation. European nations are actively investing in R&D to enhance their defense capabilities, leading to a surge in demand for advanced semiconductor solutions. The region's commitment to fostering collaboration between government agencies, research institutions, and private sector companies is further propelling the development of cutting-edge semiconductor technologies for defense applications.

Table of Contents

150 Pages
Chapter 1 Methodology
1.1 Market segmentation
1.2 Market definitions
1.3 Research design
1.4 Market size estimates and calculations
1.4.1 Approach 1: Company shares analysis
1.4.2 Approach 2: Demand side modelling approach
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis, 2021 - 2032
2.2 Disease trends
2.3 Therapy type
2.4 Route of administration trends
2.5 End user trends
2.6 Regional trends
Chapter 3 Metabolic Disorder Therapeutics Market Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of metabolic disorders
3.2.1.2 Rising R&D activities for developing novel therapeutics
3.2.1.3 Growth in awareness and screening programs
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with treatment
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.3.2 By therapy type
3.3.3 By route of administration
3.3.4 By end user
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Technology landscape
3.6 Pipeline analysis
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.1.1 Novo Nordisk A/S
4.1.2 Eli Lilly and Company
4.1.3 Sanofi
4.2 Company market share analysis, 2023
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Metabolic Disorder Therapeutics Market, By Disease
5.1 Diabetes
5.2 Hypercholesterolemia
5.3 Lysosomal storage diseases
5.3.1 Gaucher's disease
5.3.2 Metachromatic leukodystrophy
5.3.3 Hurler - Scheie
5.3.4 Sanfilipo A
5.3.5 Other lysosomal storage diseases
5.4 Obesity
5.5 Inherited metabolic disorders
Chapter 6 Metabolic Disorder Therapeutics Market, By Therapy Type
6.1 Drug therapy
6.2 Enzyme replacement therapy
6.3 Substrate reduction therapy
6.4 Gene therapy
6.5 Small molecule-based therapy
6.6 Cellular transplantation
Chapter 7 Metabolic Disorder Therapeutics Market, By Route of Administration
7.1 Oral
7.2 Parenteral
7.3 Other routes of administration
Chapter 8 Metabolic Disorder Therapeutics Market, By End Use
8.1 Hospitals
8.2 Specialty clinics
8.3 Other end users
Chapter 9 Metabolic Disorder Therapeutics Market, By Region
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
Chapter 10 Company Profile
10.1 AstraZeneca plc
10.1.1 Global overview
10.1.2 Business overview
10.1.3 Financial data
10.1.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.1.4 Product landscape
10.1.5 Strategic outlook
10.1.6 SWOT analysis
10.2 Amgen Inc.
10.2.1 Global overview
10.2.2 Business overview
10.2.3 Financial data
10.2.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.2.4 Product landscape
10.2.1 SWOT analysis
10.3 Boehringer Ingelheim International GmbH
10.3.1 Global overview
10.3.2 Business overview
10.3.3 Financial data
10.3.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.3.4 Product landscape
10.3.5 SWOT analysis
10.4 BioMarin Pharmaceutical, Inc.
10.4.1 Global overview
10.4.2 Business overview
10.4.3 Financial data
10.4.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.4.4 Product landscape
10.4.5 Strategic outlook
10.4.6 SWOT analysis
10.5 Biocon Ltd.
10.5.1 Global overview
10.5.2 Business overview
10.5.3 Financial data
10.5.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.5.4 Product landscape
10.5.5 Strategic outlook
10.5.6 SWOT analysis
10.6 Bristol-Myers Squibb Company
10.6.1 Global overview
10.6.2 Business Overview
10.6.3 Financial data
10.6.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.6.4 Product Landscape
10.6.5 SWOT analysis
10.7 Cipla
10.7.1 Global overview
10.7.2 Business Overview
10.7.3 Financial data
10.7.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.7.4 Product Landscape
10.7.5 Strategic outlook
10.7.6 SWOT analysis
10.8 CHIESI Farmaceutici S.p.A.
10.8.1 Global overview
10.8.2 Business Overview
10.8.3 Financial data
10.8.3.1 Annual sales revenue, 2022-2023 (USD Million)
10.8.4 Product Landscape
10.8.5 Strategic outlook
10.8.6 SWOT analysis
10.9 Eli Lilly and Company
10.9.1 Global overview
10.9.2 Business overview
10.9.3 Financial data
10.9.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.9.4 Product landscape
10.9.5 Strategic outlook
10.9.6 SWOT analysis
10.10 GlaxoSmithKline plc
10.10.1 Global overview
10.10.2 Business overview
10.10.1 Financial data
10.10.1.1 Annual sales revenue, 2020-2023 (USD Million)
10.10.2 Product landscape
10.10.3 SWOT analysis
10.11 Johnson & Johnson
10.11.1 Global overview
10.11.2 Business overview
10.11.3 Financial data
10.11.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.11.4 Product landscape
10.11.5 SWOT analysis
10.12 Merck KGaA
10.12.1 Global overview
10.12.2 Business Overview
10.12.3 Financial data
10.12.4 Product Landscape
10.12.5 SWOT analysis
10.13 Novo Nordisk A/S
10.13.1 Global overview
10.13.2 Business Overview
10.13.3 Financial data
10.13.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.13.4 Product landscape
10.13.5 Strategic outlook
10.13.6 SWOT analysis
10.14 Sanofi
10.14.1 Global overview
10.14.2 Business overview
10.14.3 Financial data
10.14.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.14.4 Product landscape
10.14.5 SWOT analysis
10.15 Takeda Pharmaceutical Company Limited
10.15.1 Global overview
10.15.2 Business overview
10.15.3 Financial data
10.15.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.15.4 Product landscape
10.15.5 SWOT analysis

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us